Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes-Reference-Cited by-同舟云学术

Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes

Author:

Kishimoto I.¹,Makino H.¹,Ohata Y.¹,Tamanaha T.¹,Tochiya M.¹,Kusano K.²,Anzai T.²,Toyoda K.³,Yasuda S.²,Minematsu K.³,Ogawa H.²

Affiliation:

1. Department of Endocrinology and Metabolism; National Cerebral and Cardiovascular Center; Osaka Japan

2. Department of Cardiovascular Medicine; National Cerebral and Cardiovascular Center; Osaka Japan

3. Department of Cerebrovascular Medicine; National Cerebral and Cardiovascular Center; Osaka Japan

Funder

Research Grants for Cardiovascular Diseases

Ministry of Health, Labour and Welfare

Ministry of Education, Culture, Sports, Science, and Technology

Cardiovascular Diseases of the National Cerebral and Cardiovascular Centre

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference29 articles.

4. Guidelines for the management of atrial fibrillation;The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Eur Heart J,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献